专利信息

首页 1 2 3 4 5 6 下页尾页共 228 条记录, 当前第1/23页。

专利标题：Dosage forms of risedronate

Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate a chelating agent and means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and phan-naceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alle...

专利标题：DOSAGE FORMS OF RISEDRONATE

专利权人：WARNER CHILCOTT CO LLC [US];

Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially al...

专利标题：Dosage forms of risedronate

专利权人：Warner Chilcott Company, Llc;

Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate a chelating agent and means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially allev...

专利标题：DOSAGE FORMS OF BISPHOSPHONATES

Provided is an oral dosage form comprising a bisphosphonate selected from the group consisting of a risedronate and salts thereof

专利标题：Synthesis method of risedronate sodium

专利标题：RISEDRONATE COMPOSITION AND ITS METHOD OF USE

专利权人：AJINOMOTO KK;

专利标题：IMPROVED RISEDRONATE FORMULATION

专利权人：BILGIC MAHMUT [TR];

专利标题：LOW DOSAGE FORMS OF RISEDRONATE OR ITS SALTS

Oral dosage forms comprising risedronate or a salt thereof, a chelating agent, and means for effecting delayed release of the risedronate (or salt) immediate release of the oral dosage form to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between the risedronate (or salt) and food or beverages, which interaction results in the active ingred...

专利标题：Low dosage forms of risedronate or its salts

专利权人：Warner Chilcott Company, Llc.;

Oral dosage forms comprising risedronate or a salt thereof a chelating agent and means for effecting delayed release of the risedronate (or salt) immediate release of the oral dosage form to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between the risedronate (or salt) and food or beverages which interaction results in the active ingredien...

专利标题：Low dosage forms of risedronate or its salts

专利权人：Warner Chilcott Company, Llc;

当前查询条件: [药品] 包含 'Risedronate'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. AU2011218625B2	2014/3/20
专利标题：Dosage forms of risedronate 专利权人：Warner Chilcott Company, Llc; Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate a chelating agent and means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and phan-naceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alle...

2. US2014057872A1	2014/2/27	US201314065542	2013/10/29
专利标题：DOSAGE FORMS OF RISEDRONATE 专利权人：WARNER CHILCOTT CO LLC [US]; Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate, a chelating agent, and, means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially al...

3. US20140057872A1	2014/2/27
专利标题：Dosage forms of risedronate 专利权人：Warner Chilcott Company, Llc; Oral dosage forms of a risedronate comprised of a safe and effective amount of a pharmaceutical composition comprising risedronate a chelating agent and means for effecting delayed release of the risedronate and the chelating agent in the small intestine provide immediate release of the pharmaceutical composition to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially allev...

4. US2013331361A1	2013/12/12	US201313964359	2013/8/12
专利标题：DOSAGE FORMS OF BISPHOSPHONATES 专利权人：WARNER CHILLCOTT COMPANY LLC [US]; Provided is an oral dosage form comprising a bisphosphonate selected from the group consisting of a risedronate and salts thereof

5. CN102286024B	2013/12/4
专利标题：Synthesis method of risedronate sodium 专利权人：Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.;

6. JP2013231087A	2013/11/14	JP20130169220	2013/8/16
专利标题：RISEDRONATE COMPOSITION AND ITS METHOD OF USE 专利权人：AJINOMOTO KK;

7. EP2661258A1	2013/11/13	EP20120706950	2012/1/6
专利标题：IMPROVED RISEDRONATE FORMULATION 专利权人：BILGIC MAHMUT [TR];

8. US2013183353A1	2013/7/18	US201313782495	2013/3/1
专利标题：LOW DOSAGE FORMS OF RISEDRONATE OR ITS SALTS 专利权人：WARNER CHILCOTT CO LLC [US];WARNER CHILCOTT CO LLC [US]; Oral dosage forms comprising risedronate or a salt thereof, a chelating agent, and means for effecting delayed release of the risedronate (or salt) immediate release of the oral dosage form to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between the risedronate (or salt) and food or beverages, which interaction results in the active ingred...

9. US20130183353A1	2013/7/18
专利标题：Low dosage forms of risedronate or its salts 专利权人：Warner Chilcott Company, Llc.; Oral dosage forms comprising risedronate or a salt thereof a chelating agent and means for effecting delayed release of the risedronate (or salt) immediate release of the oral dosage form to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between the risedronate (or salt) and food or beverages which interaction results in the active ingredien...

10. US20130177645A1	2013/7/11
专利标题：Low dosage forms of risedronate or its salts 专利权人：Warner Chilcott Company, Llc; Oral dosage forms comprising risedronate or a salt thereof a chelating agent and means for effecting delayed release of the risedronate (or salt) immediate release of the oral dosage form to the small intestine of the mammal subject and pharmaceutically effective absorption of the bisphosphonate with or without food or beverages. The present invention substantially alleviates the interaction between the risedronate (or salt) and food or beverages which interaction results in the active ingredien...

下载范围

下载内容